We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

151 hedge funds and large institutions have $1.38B invested in Esperion Therapeutics in 2015 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 70 increasing their positions, 26 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

169% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 26

125% more call options, than puts

Call options by funds: $139M | Put options by funds: $61.6M

29% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 35

7% more funds holding

Funds holding: 141151 (+10)

0% more capital invested

Capital invested by funds: $1.38B → $1.38B (+$5.87M)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
151
Holders Change
+10
Holders Change %
+7.09%
% of All Funds
4.07%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.08%
New
45
Increased
70
Reduced
26
Closed
35
Calls
$139M
Puts
$61.6M
Net Calls
+$77.3M
Net Calls Change
+$74.3M
Name Holding Trade Value Shares
Change
Change in
Stake
FAAS
176
First Allied Advisory Services
California
-$463K -5,000 Closed
SM
177
Sabby Management
Florida
-$489K -5,000 Closed
CC
178
Caxton Corporation
New Jersey
-$340K -3,671 Closed
SEC
179
Seven Eight Capital
New York
-$324K -3,500 Closed
Wellington Management Group
180
Wellington Management Group
Massachusetts
-$253K -2,730 Closed
CC
181
Curian Capital
Colorado
-$223K -2,413 Closed
CI
182
Cowen Inc
New York
-$219K -2,364 Closed
QT
183
Quantbot Technologies
New York
-$186K -2,015 Closed
TSW
184
Thompson Siegel & Walmsley
Virginia
-$130K -1,400 Closed
MCM
185
Mazama Capital Management
Oregon
-$19K -202 Closed
PA
186
Perceptive Advisors
New York
-$9.98K -102 Closed